Akemi Rocío Plaza Alcívar

Akemi Rocío Plaza Alcívar

Auto-generated profile, based on publicly available information

Akemi Rocío Plaza Alcívar

Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2025 in Salud, Ciencia y Tecnología
Verified
Journal Article
Open access
PDF file
JBJames Edward Neira Borja
James Edward Neira Borja
AAAkemi Rocío Plaza Alcívar
Akemi Rocío Plaza Alcívar
KPKatherine Nicole Estay Peralta
Katherine Nicole Estay Peralta
MZMaría Auxiliadora Calero Zea
María Auxiliadora Calero Zea
MRMaría de Fátima Vaca Rojas
María de Fátima Vaca Rojas
Introduction:The collaboration between internal medicine, dermatology, and radiology forms a diagnostic triad essential for the accurate detection and management of complex, multi-system diseases. Each specialty provides unique insights that, when integrated, enhance patient care through early diagnosis and comprehensive treatment planning.Methods:This narrative review synthesizes existing literature on the collaborative practices between internal medicine, dermatology, and radiology. Key themes such as diagnostic accuracy, patient outcomes, challenges, and strategies to improve collaboration were explored through a qualitative analysis of studies published in peer-reviewed journals, reports, and case studies.Results:The review highlights several benefits of interdisciplinary collaboration, including improved diagnostic precision, early disease detection, and better management of conditions with cutaneous manifestations. Challenges include communication barriers, limited resources, and the need for specialized knowledge across fields. Strategies such as regular multidisciplinary meetings, technology integration (e.g., telemedicine, AI), and interdisciplinary education were identified as essential for overcoming these barriers and enhancing teamwork.Conclusion:Collaboration between internal medicine, dermatology, and radiology improves diagnostic outcomes and patient care. While challenges persist, strategic solutions such as technological integration and continuous professional education can foster more effective multidisciplinary partnerships. Enhanced collaboration across these specialties is crucial for advancing healthcare and ensuring optimal patient management.

24 July 2026
Verified
Book
Closed access
AAAkemi Rocío Plaza Alcívar
Akemi Rocío Plaza Alcívar
MAMateo Sebastián Moya Artieda
Mateo Sebastián Moya Artieda
PGPaola Vanessa Flores Guayaquil
Paola Vanessa Flores Guayaquil
MGMichael Alexander Gomez Ghilino
Michael Alexander Gomez Ghilino
JYJessica Belén Guamán Yunga
Jessica Belén Guamán Yunga
Avances Contemporáneos en Dermatología es una obra concebida para ofrecer una visión actualizada de los principales desafíos y progresos en el diagnóstico, tratamiento y comprensión de las enfermedades de la piel. A través de un enfoque basado en la evidencia científica y la práctica clínica, el libro reúne temas de relevancia creciente, incorporando innovaciones terapéuticas, nuevas herramientas diagnósticas y estrategias de manejo orientadas a optimizar la atención dermatológica. Su contenido constituye un recurso de gran utilidad para dermatólogos, médicos generales, residentes y profesionales de la salud que buscan fortalecer sus conocimientos y mantenerse al día con la evolución constante de esta especialidad.

1 July 2024 in Ibero-American Journal of Health Science Research
Verified
Journal Article
Open access
FNFernanda De Las Mercedes López Naveda
Fernanda De Las Mercedes López Naveda
AAAkemi Rocío Plaza Alcívar
Akemi Rocío Plaza Alcívar
ICIrina Talia Guzmán Chávez
Irina Talia Guzmán Chávez
ACAna Karina Guamán Cevallos
Ana Karina Guamán Cevallos
AVAnthony Jesús Pastrana Villares
Anthony Jesús Pastrana Villares
ABAna Gabriela Castro Bojorque
Ana Gabriela Castro Bojorque
Background: Atopic dermatitis (AD)_ chronic inflammatory skin disorder, has affected the global population. Specifically, it is seen as more common in children about 10-20% prevalence in children’s and 2% among adults. Traditional treatments are insufficient for moderate to severe cases and necessitate new therapeutic options. Janus kinase (JAK) inhibitors is promising class of drugs due to their ability to modulate key inflammatory pathways involved in AD. Methodology: Systematic review was conducted using Cochrane Library database, PubMed, and Embase. Keywords and MeSH terms identified studies focusing on adult patients with moderate to severe AD. Inclusion criteria encompassed studies evaluating efficacy and safety of JAK inhibitors. Data extraction was performed using standardized forms, Cochrane Risk of Bias Tool conducted. Most of the articles are selected which are published in 2024 to keep our research up-to-date. Results: We have analyzed data from several studies evaluating the efficacy and safety of JAK inhibitors, most commonly abrocitinib, upadacitinib, and baricitinib. They have shown efficacy in reducing eczema symptoms with EASI-75 response rates of up to 80% for upadacitinib and 71% for abrocitinib. Higher doses of JAK inhibitors raised safety concerns like heart diseases, infections, and acne, but the standard recommended dose stood beneficial in reducing eczema. Conclusion: JAK inhibitors are advancements in the treatment of moderate to severe atopic dermatitis. They offer substantial symptom relief and improved quality of life.

15 October 2025 in Sapienza: International Journal of Interdisciplinary Studies
Verified
Journal Article
Open access
EPElizabeth Arellano Pacheco
Elizabeth Arellano Pacheco
JRJessica Marissa García Rodríguez
Jessica Marissa García Rodríguez
FOFátima Esmeralda Ortega Ortega
Fátima Esmeralda Ortega Ortega
ACAlmeida Orellana Paola Carolina
Almeida Orellana Paola Carolina
AAAkemi Rocío Plaza Alcívar
Akemi Rocío Plaza Alcívar
SGStephanie Saldaña Guerrero
Stephanie Saldaña Guerrero
Introduction: Pediatric skin tumors are rare, accounting for less than 2% of childhood malignancies, and 20–30% of pediatric melanomas are initially misdiagnosed. Although adult-focused AI models for skin cancer often achieve AUC values above 0.90, their applicability in children is limited by scarce pediatric data and minimal external validation. This review synthesizes current evidence on the diagnostic accuracy and clinical validation of AI models for automated detection of pediatric skin tumors. Methods: We systematically searched PubMed, Embase, Scopus, Web of Science, and the Cochrane Library for studies published from January 2000 through March 2025. Eligible studies evaluated AI-based diagnosis or classification of skin tumors in pediatric populations and reported diagnostic accuracy metrics. Risk of bias was assessed. Results: Nine studies met inclusion criteria, but only two provided primary quantitative pediatric data. One study that incorporated 1,536 pediatric images into model training and tested performance in a pediatric set (n = 674) demonstrated a 7% mean AUC improvement (p = 0.003) and 162 fewer false positives (p = 0.0014). An earlier model trained predominantly on adult images achieved high sensitivity (98%) but low specificity (44%). Three systematic reviews reported diagnostic accuracies of 67–99% for general skin cancer detection, consistently emphasizing the severe shortage of pediatric cases in major image repositories. Additional narrative reviews and one protocol confirmed that fewer than 10% of AI dermatology studies focus on children. Conclusions: AI shows meaningful potential for improving pediatric skin tumor detection, and inclusion of pediatric data clearly enhances performance. However, progress is constrained by limited high-quality datasets and a lack of rigorous validation. Dedicated pediatric image repositories and prospective clinical trials are essential for advancing reliable clinical implementation.

24 June 2026
Verified
Book
Closed access
MPMónica Nataly Uvidia Parra
Mónica Nataly Uvidia Parra
ASAngie Anais Zea Salazar
Angie Anais Zea Salazar
MVMaría José Guerrero Vásquez
María José Guerrero Vásquez
AAAkemi Rocío Plaza Alcívar
Akemi Rocío Plaza Alcívar
MGMaría Andreina Fuentes Guin
María Andreina Fuentes Guin
Dermatología Poco Frecuente en Atención Primaria reúne conocimientos esenciales para el reconocimiento, diagnóstico y manejo de enfermedades dermatológicas menos habituales que pueden presentarse en el primer nivel de atención. Con un enfoque práctico, actualizado y orientado a la toma de decisiones clínicas, la obra proporciona herramientas para identificar signos de alarma, establecer diagnósticos diferenciales y realizar una derivación oportuna cuando sea necesario. Está dirigida a médicos generales, médicos familiares y profesionales de la salud interesados en fortalecer sus competencias en dermatología clínica.